ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation
Journal of Medical Virology · 2026
DOI: 10.1002/jmv.70783 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Xuefei Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Immunity, Innate, Herpesvirus 4, Human, Virus Activation, Epstein-Barr Virus Infections. Die Arbeit nennt 42 Literaturangaben. Gefördert von: The National Natural Science Foundations of China.
Abstract (Originalsprache)
Epstein‐Barr virus (EBV) is a member of the gamma‐herpesvirus subfamily that is prevalent in the human population. There are two phases of EBV infection: latent infection and lytic infection. During lytic reactivation, host innate immune responses are activated to restrict EBV replication. Here, we identified ETS translocation variant 5 (ETV5) as a negative regulator of innate immune responses to facilitate EBV reactivation. ETV5 expression was upregulated by the EBNA1/BRD7 axis, which had been previously described by us, during EBV latent infection. When EBV was induced into lytic replication, the expression of ETV5 was further increased, and ETV5 overexpression dramatically enhanced the lytic replication of EBV. Mechanistically, upon EBV reactivation, the overexpression of ETV5 suppressed the activation of TANK‐binding kinase 1 and interferon regulatory factor 3 (IRF3), as well as the transcription of interferon beta (IFNB1) gene and interferon‐stimulated genes (ISGs). The effect of ETV5 knockdown could be reversed by an inhibitor of innate immunity pathway. These findings position ETV5 as a critical accelerator of EBV reactivation through immune evasion, revealing new therapeutic targets for managing EBV‐associated diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Xiangya School of Basic Medical Sciences, Central South University, Changsha, Hunan, China.
- NHC Key Laboratory of Carcinogenesis, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University, Changsha, Hunan, China.
- Department of Microbiology, School of Basic Medical Sciences, Xinjiang Medical University, Urumqi, China.
ORCID-Profile: Jianhong Lu
Förderung
- The National Natural Science Foundations of China
Zitieren
APA
Liao, X., Chen, M., Yang, L., Jiang, M., Xin, Y., Yan, H., Qin, Q., & Lu, J. (2026). ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation. Journal of Medical Virology. https://doi.org/10.1002/jmv.70783
Vancouver
Liao X, Chen M, Yang L, Jiang M, Xin Y, Yan H, et al. ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation. Journal of Medical Virology. 2026. doi:10.1002/jmv.70783
BibTeX
@article{Liao2026,
author = {Liao, Xuefei and Chen, Mengdi and Yang, Li and Jiang, Mingjuan and Xin, Yujie and Yan, Huirong and Qin, Qingshuang and Lu, Jianhong},
title = {ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation},
journal = {Journal of Medical Virology},
year = {2026},
doi = {10.1002/jmv.70783}
}
EUVIMED